Cetera Investment Advisers Iovance Biotherapeutics, Inc. Transaction History
Cetera Investment Advisers
- $55.9 Billion
- Q2 2025
A detailed history of Cetera Investment Advisers transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 31,814 shares of IOVA stock, worth $73,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,814
Previous 33,608
5.34%
Holding current value
$73,490
Previous $111,000
51.35%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IOVA
# of Institutions
291Shares Held
232MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$66.9 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$55.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$49 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$27.3 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $365M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...